脑部放疗，上午比下午敏感许多！
?. W8 n$ s6 h7 B5 |; T( ^4 n4 A
( q6 O! E: Q/ K; P; l+ r" p- ? ^5 ?4 m- L9 m! [
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.* M5 V4 p1 l6 w% {
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
+ F# ]6 g% Z2 [ S6 R3 e# URahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.- p4 \3 U1 e" _2 Z; T% K/ J
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.5 f) u9 R7 b& t5 @, N; y# y0 |
; b9 ]6 n+ l7 BAbstract; @7 I. ~% G* e7 z9 ]: f1 k
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
4 v$ u2 G( c9 ]
5 g3 J1 \% @) |! k( a0 jMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.* @7 u; a. b# G2 L. S! M
9 \- c* @! T8 l V' {, x
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
8 `6 f) ~& @- ?" Y. B8 f
$ f3 f" l. c# S+ O: |% L* R: VCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.6 I* w7 ~+ z% r8 y
+ O/ [4 L/ a# I |
11011102001537 )
显身卡
